In September 2007, the largest study of COPD in the United States was funded by the NHLBI to broadly address unanswered questions about the causes of COPD. The study was funded as paired projects at National Jewish Health in Denver, Colorado, and Brigham and Women’s Hospital in Boston, Massachusetts, under the direction of Co-Principal Investigators Dr. James D. Crapo, FCCP; and Dr. Edwin K. Silverman, PhD.
Read Full Article>>
FOR IMMEDIATE RELASE - Coralville, IA – March 28, 2012 - VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today that the company has appointed Philippe Raffy, Ph.D. as Chief Technology Officer (CTO). Dr. Raffy's inclusion to the VIDA management team strengthens the technical leadership and expertise in pulmonary image analysis.
Read Release>>
Presentation by Momen W. Wahidi, MD, MBA, FCCP
Director, Interventional Pulmonology & Bronchoscopy
Associate Professor of Medicine, Duke University
Recorded at CHEST 2011.
Watch Video >>
Mountain View, CA – February 21, 2012: The cover of The American Journal of Respiratory and Critical Care Medicine (February 15, 2012; 185 (4)) features images from VIDA Diagnostics' proprietary quantitative imaging software, Apollo.
Read More>>
Mountain View, CA – February 3, 2012: VIDA Diagnostics, Inc. today announced the opening of a new branch office in Mountain View, CA in Silicon Valley as part of the company's initiative to develop key growth markets and support its global commercialization strategy.
Read Press Release>>
CAREERS with VIDA
VIDA is seeking a qualified System Administration IT Engineer for our Coraville location. Please visit our careers page for position qualifications and application information.
VIDA Careers>>
VIDA PEER REVIEWED JOURNAL CITEA Combined Pulmonary-Radiology Workshop for Visual Evaluation of COPD: Study Design, Chest CT Findings and Concordance with Quantitative Evaluation.
Download PDF>
VIDA'S APOLLO SOFTWARE IMAGES ON COVER OF AJRCCM JOURNAL
The cover of The American Journal of Respiratory and Critical Care Medicine (February 15, 2012; 185 (4)) features images from VIDA Diagnostics' proprietary quantitative imaging software, Apollo.
Read More>>
RECENT NEWS/ANNOUNCEMENTS· CLINICAL VALIDATION: VIDA Software Used for Analyzing CT Scans In Largest National Study on COPD
· CAREERS: VIDA is seeking applicants for System Administration IT Engineer position
· INDUSTRY NEWS: American Lung Association supports CT screening for smokers
· INDUSTRY NEWS: Emphysema on CT scans tied to higher lung cancer risk
· INDUSTRY NEWS: Imaging equipment services sector projected to rise
· VIDA's corporate partner, Uptake Medical, begins clinical procedures in Europe.
EVENTS CALENDAR
ATS 2012 ● The Annual International Conference of the American Thoracic Society.
May 18-23. San Francisco, CA
WCBIP 2012 ● 17th World Congress for Bronchology and Interventional Pulmonology
June 15-18. Cleveland, OH
ERS 2012 ● The Annual Congress of the European Respiratory Society.
September 1-5. Vienna, Austria
VIDA Diagnostics is a leader in clinically-validated quantitative pulmonary analysis software for the early detection, evaluation and aiding of treatment of pulmonary disease including COPD, emphysema, lung cancer, and asthma. FDA approved and CE certified, VIDA's analysis methodology has been successfully tested in multiple academic, pulmonary device, and pharmaceutical clinical trials.